Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. [electronic resource]
Producer: 20060919Description: 7276-84 p. digitalISSN:- 0008-5472
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antigens, CD -- immunology
- Antigens, Differentiation -- immunology
- Antineoplastic Combined Chemotherapy Protocols -- immunology
- Autoimmunity -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- CTLA-4 Antigen
- Colonic Neoplasms -- immunology
- Female
- Humans
- Immunization, Passive -- methods
- Mice
- Mice, Inbred C57BL
- Receptors, Nerve Growth Factor -- immunology
- Receptors, Tumor Necrosis Factor -- immunology
- T-Lymphocytes, Regulatory -- immunology
- Tumor Necrosis Factor Receptor Superfamily, Member 9
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.